BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8923048)

  • 21. Some pharmacokinetic parameters of ampicillin/sulbactam combination after intravenous and intramuscular administration to goats.
    Espuny A; Carceles CM; Vicente MS; Escudero E
    Vet Q; 1996 Dec; 18(4):136-40. PubMed ID: 8972061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery.
    Wildfeuer A; Müller V; Springsklee M; Sonntag HG
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1772-6. PubMed ID: 1952846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of sulbactam/ampicillin in serum and lung tissue.
    Frank U; Schmidt-Eisenlohr E; Joos-Württemberger A; Hasse J; Daschner F
    Infection; 1990; 18(5):307-9. PubMed ID: 2276827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
    Majcher-Peszynska J; Loebermann M; Klammt S; Frimmel S; Mundkowski RG; Welte T; Reisinger EC; Drewelow B;
    Infection; 2014 Feb; 42(1):79-87. PubMed ID: 23904004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of ampicillin-sulbactam in anuric patients: dosing optimization for prophylaxis during cardiovascular surgery.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Yamamoto H; Imoto Y; Morikawa N; Takeda Y
    Int J Clin Pharm; 2016 Aug; 38(4):771-5. PubMed ID: 27001408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
    Fernández-Varón E; Escudero-Pastor E; Cárceles-Rodríguez CM
    Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.
    Lorenzen JM; Broll M; Kaever V; Burhenne H; Hafer C; Clajus C; Knitsch W; Burkhardt O; Kielstein JT
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):385-90. PubMed ID: 22223613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic prophylaxis in transurethral surgery: a comparison of sulbactam-ampicillin and cefoxitin.
    Dørflinger T; Madsen PO
    Infection; 1985; 13(2):66-9. PubMed ID: 2987133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.
    Valcke YJ; Rosseel MT; Pauwels RA; Bogaert MG; Van der Straeten ME
    Antimicrob Agents Chemother; 1990 Jun; 34(6):958-62. PubMed ID: 2393293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.
    Hampel B; Lode H; Bruckner G; Koeppe P
    Drugs; 1988; 35 Suppl 7():29-33. PubMed ID: 3220007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of sulbactam-ampicillin/sultamicillin in mixed infections.
    Moosdeen F
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S1. PubMed ID: 10526866
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and pharmacokinetic studies on intravenous administration of sulbactam/ampicillin in pediatrics].
    Sato H; Narita A; Suzuki H; Nakazawa S; Matsumoto K; Nakanishi Y; Niino K; Nakazawa S
    Jpn J Antibiot; 1989 Mar; 42(3):623-38. PubMed ID: 2746846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose pharmacokinetics of intravenous ampicillin plus sulbactam in healthy elderly and young adult subjects.
    Rho JP; Jones A; Woo M; Castle S; Smith K; Bawdon RE; Norman DC
    J Antimicrob Chemother; 1989 Oct; 24(4):573-80. PubMed ID: 2613605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ampicillin/sulbactam in patients undergoing colorectal surgery: measurements in serum, the colonic wall and in tissue at the incision site.
    Wenzel M; Wildfeuer A; Gutsche F
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S35-9. PubMed ID: 18611718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
    Lode H; Springsklee M
    Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.
    Matsubara K; Matsumoto K; Yokoyama Y; Watanabe E; Enoki Y; Shigemi A; Ikawa K; Terazono H; Morikawa N; Ohshige T; Takeda Y
    Biol Pharm Bull; 2021; 44(5):732-736. PubMed ID: 33952829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.